BioCentury
ARTICLE | Company News

Berlex gets approvable letter for Bonefos

January 7, 2005 8:00 AM UTC

Berlex received an approvable letter from FDA for Bonefos clodronate as an adjuvant treatment for reducing the occurrence of bone metastases in stage II/III breast cancer patients. The company said it...